Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-001732
Filing Date
2018-03-16
Accepted
2018-03-16 09:04:40
Documents
4
Period of Report
2018-05-03
Effectiveness Date
2018-03-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2234866zdef14a.htm DEF 14A 403331
2 G18891.JPG g18891.jpg GRAPHIC 16439
3 G82292BGI001.GIF g82292bgi001.gif GRAPHIC 76474
4 G82292BGI002.GIF g82292bgi002.gif GRAPHIC 68314
  Complete submission text file 0001047469-18-001732.txt   626719
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37990 | Film No.: 18694331
SIC: 2834 Pharmaceutical Preparations